Ori Biotech
PrivateLast Round
Series B
Jan 18, 2022
Total Funding Raised
$139.4M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Ori Biotech is a biotechnology company that specializes in automated manufacturing technology for cell and gene therapies, enhancing process efficiency and scalability for therapeutic developers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Smart Manufacturing
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ori Biotech Comparables
Compare Ori Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Adva Biotechnology | 90% | |
| Cellular Origins | 88% | |
| Cellares | 87% |
Ori Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 18, 2022 | ||||
| Series A | Oct 14, 2020 | ||||
| Seed | Jan 8, 2020 |
Key People
Founding team and executive leadership
Ori Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Amadeus Capital Partners | Series B, Series A, Seed |
| Northpond Ventures | Series B, Series A |
| Chimera Investment LLC | Series B |
| Kindred Capital | Seed, Series A |
| Novalis LifeSciences | Series B |
| Puhua Capital | Series B |
| Northpond Ventures | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 75% MoM, reaching 10K.
- Jul 2, 2025
Sponsored session on commercial viability for cell and gene therapies.
Recent news
Latest coverage and updates
- receives_financingOct 20, 2026
Ori Biotech Ltd raises a total of $143M across five funding rounds, comprising three Seed and two Early-Stage rounds.
Ori Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Ori Biotech's valuation, stock price, and market status.
Is Ori Biotech a public or private company?
Ori Biotech is a private company.
What is the current stock price of Ori Biotech?
Ori Biotech is a private company, so its shares have no public market price. Caplight tracks Ori Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Ori Biotech worth (valuation)?
Valuation information for Ori Biotech is not publicly available.
Can I buy Ori Biotech stock?
Ori Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Ori Biotech's last funding round?
Ori Biotech's most recent funding round was Series B on January 18, 2022.
Who are the main investors in Ori Biotech?
Key investors in Ori Biotech include Amadeus Capital Partners, Northpond Ventures, Novalis LifeSciences, Northpond Ventures, Delin Ventures.
Will Ori Biotech IPO soon?
No public IPO plans have been announced for Ori Biotech.
How can I track Ori Biotech secondary market activity?
Caplight tracks bids, offers, and trades in Ori Biotech's shares on secondary markets.